Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Saraswanti Anugerah Makmur Tbk. (SAMF) Price & Performance

Brigit Biofarmaka Teknologi Tbk.Trade
Saraswanti Anugerah Makmur Tbk.Trade

Price performance (Past 24H)

Key statistics

Brigit Biofarmaka Teknologi Tbk. vs Saraswanti Anugerah Makmur Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Saraswanti Anugerah Makmur Tbk. trades at Rp280 (market cap 2.89T, 75.7K 24h volume). The key difference: Saraswanti Anugerah Makmur Tbk. is far larger — about 16.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 75.7K). Which is the better fit depends on your goals.

OBATSAMF
Market Cap
172.82B2.89T
Volume
592.2K75.7K
Lot
5.92K757
Turnover
147.05M21.14M
Average Price
248.31279.31
Value
147.05M21.14M
Indicative Equilibrium Price
254276
Indicative Equilibrium Volume
10134

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OBAT
View details
SAMF
View details

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT

About Saraswanti Anugerah Makmur Tbk.

PT. Saraswanti Anugerah Makmur Tbk. (the Company) was established based on the Notarial Deed of Titiek Lintang Trenggonowati, S.H., No.15 dated June 18, 1998, notary in Surabaya.

Read more on SAMF